Livzon Pharmaceutical Group Inc. (SHE:000513)
China · Delayed Price · Currency is CNY 26.41
-0.35 (-1.31%)
Aug 31, 2026, 3:04 PM CST
SHE:000513 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 10,748 | 12,020 | 11,812 | 12,430 | 12,630 | 12,064 |
Revenue Growth | -8.93% | 1.76% | -4.97% | -1.58% | 4.69% | 14.67% |
Gross Profit Gross Profit Growth | 6,821 | 7,885 | 7,564 | 7,658 | 8,053 | 7,754 |
Operating Income Operating Income Growth | 2,266 | 2,627 | 2,536 | 1,921 | 1,932 | 1,917 |
Net Income Net Income Growth | 1,674 | 2,023 | 2,061 | 1,954 | 1,909 | 1,776 |
Earnings Per Share EPS Growth | 1.88 | 2.27 | 2.24 | 2.10 | 2.04 | 1.90 |
EPS Growth | -21.26% | 1.16% | 6.64% | 2.94% | 7.47% | 3.73% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
China China Growth | 8,570 | 9,967 | 9,977 | 10,754 | 10,959 | 10,389 |
Overseas Overseas Growth | 2,055 | 1,930 | 1,724 | 1,571 | 1,565 | 1,539 |
Total Total Growth | 10,625 | 11,897 | 11,701 | 12,326 | 12,524 | 11,928 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 8,305 | 10,921 | 10,917 | 11,408 | 10,519 | 9,329 |
Total Debt Total Debt Growth | 3,456 | 3,060 | 3,983 | 4,141 | 3,619 | 2,694 |
Net Cash (Debt) Net Cash Growth | 4,849 | 7,861 | 6,934 | 7,266 | 6,901 | 6,635 |
Net Cash Growth | -32.70% | 13.37% | -4.57% | 5.29% | 4.01% | -17.58% |
Net Cash Per Share Net Cash Per Share Growth | 5.45 | 8.80 | 7.53 | 7.81 | 7.37 | 7.09 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 3,221 | 3,145 | 2,979 | 3,249 | 2,773 | 1,902 |
Capital Expenditures CapEx Growth | -392.11 | -574.14 | -570.16 | -820.45 | -940.15 | -1,309 |
Free Cash Flow Free Cash Flow Growth | 2,829 | 2,571 | 2,409 | 2,428 | 1,833 | 593.23 |
Free Cash Flow Growth | 15.51% | 6.73% | -0.81% | 32.52% | 208.91% | -60.81% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Gross Margin | 63.46% | 65.60% | 64.03% | 61.61% | 63.76% | 64.28% |
Operating Margin | 21.08% | 21.85% | 21.47% | 15.46% | 15.30% | 15.89% |
Pretax Margin | 21.96% | 23.81% | 23.76% | 19.17% | 18.45% | 18.62% |
Profit Margin | 15.58% | 16.83% | 17.45% | 15.72% | 15.12% | 14.72% |
FCF Margin | 26.32% | 21.39% | 20.39% | 19.54% | 14.51% | 4.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 1.430 | 1.430 | 1.100 | 1.350 | 1.600 | 1.300 |
Dividend Per Share Growth | 30.00% | 30.00% | -18.52% | -15.63% | 23.08% | 4.00% |
Dividend Yield | 4.81% | 4.35% | 3.12% | 4.31% | 5.74% | 3.92% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
PE Ratio | 14.02 | 13.81 | 14.90 | 14.48 | 14.38 | 18.19 |
Forward PE | 11.26 | 13.40 | 15.83 | 17.25 | 16.36 | 18.28 |
P/FCF Ratio | 7.34 | 10.87 | 12.75 | 11.65 | 14.98 | 54.46 |
PS Ratio | 1.93 | 2.33 | 2.60 | 2.28 | 2.17 | 2.68 |